NCT04668898View on ClinicalTrials.gov

LRRK2, GBA and Other Genetic Biomarkers in Eastern European (Ashkenazi) Jews With and Without Parkinson's Disease

CompletedOBSERVATIONAL
Enrollment

203

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

April 1, 2025

Study Completion Date

April 1, 2025

Conditions
Parkinson DiseaseLRRK2GBA Gene Mutation
Trial Locations (1)

11104

Mount Sinai-- Downtown Union Square, New York

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT04668898 - LRRK2, GBA and Other Genetic Biomarkers in Eastern European (Ashkenazi) Jews With and Without Parkinson's Disease | Biotech Hunter | Biotech Hunter